In this week's issue:

  • France's most storied independent bookshop chain — 16 stores, 140 years old, 500 employees — in court-supervised reorganization and betting its survival on used books
  • Justin Garson's new history of how NIMH psychiatrists used LSD and amphetamines to induce schizophrenia in human subjects, and what it did to American psychiatry
  • Deborah Lutz's first full Emily Brontë biography in over twenty years, drawing on previously inaccessible manuscripts to present a very different Brontë than the legend
  • A GWU Illiberalism Studies Program essay tracing how a little-known Argentine writer became the dominant intellectual of the transnational Spanish-speaking radical right

Here we go.

Top Stories

Gibert, France's Oldest Independent Bookshop Chain, Files for Court-Supervised Reorganization

Financière Palidis, the legal owner of the groupe Gibert — known commercially as Gibert Joseph and Gibert Jeune — filed for redressement judiciaire (court-supervised reorganization) on Monday, April 27. The Tribunal de commerce de Paris validated the filing on Tuesday, April 28, opening a six-month observation period during which the company will operate under court supervision while it develops a restructuring plan. The chain, founded in 1886 and headquartered in Paris's Latin Quarter, reunified its two historic brands in 2017 and today runs 16 stores across 12 French cities, including five in Paris, with 500 employees.

The numbers tell the story: 2025 revenue was €86 million, of which used books accounted for 35% (approximately €30 million). Management has cited what it calls a "scissors effect": fixed costs — particularly rent and energy — have risen sharply while the new-book market has contracted and margin compression has tightened further. The chain's response is to bet its recovery on the second-hand trade, with a plan to double used-book revenue to €60 million by 2029, effectively reorienting the business model around the segment that has held up. Employee representative Sophie Rachet expressed concern for the chain's 500 workers, whose situation will depend on the shape of any reorganization plan submitted during the observation period.

This story belongs to a different crisis than the editorial capture controversies (Bolloré/Grasset) that have dominated French publishing discourse in recent months. Where that story is about who controls the content of books, the Gibert filing is about the structural economics of independent bookselling — the squeeze between commercial landlords, energy markets, and a declining market for new books at compressed margins. Gibert's cultural weight is hard to overstate: as The Times has put it, the Latin Quarter stores are something close to a "cathedral" of French literary life, a city institution that has supplied generations of students and scholars. Whether the used-book pivot is a genuine survival strategy or a slower form of decline will become clearer over the six-month observation period.

Sources: France 24 / AFP, April 27 · France Info, April 28 · The Times

Upcoming Events

The Madness Pill: How NIMH Researchers Used Psychedelics to Chase the Dopamine Hypothesis

Justin Garson's new book The Madness Pill: One Doctor's Quest to Understand Schizophrenia (St. Martin's Press, April 28, 2026) traces the rise and fall of the dopamine hypothesis of schizophrenia through a largely forgotten chapter in the history of American psychiatry. Garson — a philosopher whose previous book Madness: A Philosophical Exploration was published by Oxford University Press in 2022 — focuses on NIMH-funded researchers who, from the mid-1960s through the early 1970s, administered LSD, STP, and high-dose amphetamines to both animal and human subjects in an attempt to model schizophrenia experimentally. Among the central figures are Burton Angrist, a Bellevue psychiatrist, and Solomon Snyder, a Johns Hopkins professor who would later become one of the most decorated neuroscientists of his generation.

The book's argument, as reviewed by Christopher Lane (Professor Emeritus of Medical Humanities at Northwestern University) in his Psychology Today "Side Effects" blog, is that this experimental program was decisive in shaping the dopamine hypothesis — the theory, dominant for decades, that schizophrenia results from excess dopaminergic activity. The research strategy was straightforward and, in retrospect, troubling: if psychedelics and stimulants could induce psychosis, then the neurochemical pathways they acted on might explain schizophrenia itself. The hypothesis generated a generation of antipsychotic drug development but also, Lane's review suggests, a kind of pharmacological tunnel vision that may have foreclosed other explanatory frameworks.

Lane's review, titled "The Drugs Meant to Induce Madness," emphasizes the book's contribution to the history and philosophy of psychiatry — a field increasingly asking how specific theoretical commitments became institutionally entrenched. The timing is notable: the book appears amid a broader cultural reassessment of both psychedelics (now the subject of serious therapeutic research) and the limits of the dopamine hypothesis (which has faced sustained empirical challenge since the 1990s). Garson's contribution is to historicize how that hypothesis got built in the first place, and at what human cost.

Sources: Christopher Lane, Psychology Today, April 28, 2026

Odds and Ends

That's the Issue

If this issue was worth your time:

  • Forward it to one writer, scholar, or reader who would actually use it
  • Reply with a thought — what hit, what missed, what you want more of
  • Share it on social if something here sparked something for you

Thanks for reading. See you tomorrow.

Was this forwarded to you? Subscribe at indiescholars.com

Keep Reading